Joseph Shulman's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 22,500 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 22,500 | 22,500 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 15,000 | 15,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 16,968 | 25,477 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.99 per share. | 01 Feb 2026 | 6,507 | 18,970 (0%) | 0% | 109.0 | 709,198 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 6,250 | 18,750 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 4,125 | 8,250 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 3,937 | 3,937 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 2,656 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 30 Oct 2025 | 9,748 | 18,257 (0%) | 0% | 30.7 | 298,874 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Oct 2025 | 9,748 | 0 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 115.24 per share. | 30 Oct 2025 | 9,748 | 8,509 (0%) | 0% | 115.2 | 1,123,398 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 115.01 per share. | 28 Oct 2025 | 2,815 | 8,509 (0%) | 0% | 115.0 | 323,750 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 28 Oct 2025 | 2,094 | 10,603 (0%) | 0% | 27.4 | 57,271 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2025 | 2,094 | 12,563 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2025 | 721 | 9,748 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 28 Oct 2025 | 721 | 11,324 (0%) | 0% | 30.7 | 22,106 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 12,344 | 10,469 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 16 Oct 2025 | 12,344 | 22,946 (0%) | 0% | 30.7 | 378,467 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 112.06 per share. | 16 Oct 2025 | 8,332 | 11,921 (0%) | 0% | 112.1 | 933,646 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 112.81 per share. | 16 Oct 2025 | 3,412 | 8,509 (0%) | 0% | 112.8 | 384,908 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 110.95 per share. | 16 Oct 2025 | 2,693 | 20,253 (0%) | 0% | 110.9 | 298,784 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 16 Oct 2025 | 2,093 | 10,602 (0%) | 0% | 27.4 | 57,244 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2025 | 2,093 | 14,657 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 105.30 per share. | 02 Sep 2025 | 16,781 | 8,509 (0%) | 0% | 105.3 | 1,767,006 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 14,687 | 22,813 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.66 per share. | 02 Sep 2025 | 14,687 | 25,290 (0%) | 0% | 30.7 | 450,303 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 02 Sep 2025 | 2,094 | 10,603 (0%) | 0% | 27.4 | 57,271 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2025 | 2,094 | 16,750 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 21 Aug 2025 | 4,188 | 12,697 (0%) | 0% | 27.4 | 114,542 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2025 | 4,188 | 18,844 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 100.07 per share. | 21 Aug 2025 | 4,188 | 8,509 (0%) | 0% | 100.1 | 419,091 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 3,984 | 7,969 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 90.08 per share. | 11 Aug 2025 | 3,984 | 8,509 (0%) | 0% | 90.1 | 358,891 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 11 Aug 2025 | 3,984 | 12,493 (0%) | 0% | 6.8 | 27,091 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 7,969 | 11,953 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Jul 2025 | 7,969 | 16,478 (0%) | 0% | 6.8 | 54,189 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 09 Jul 2025 | 3,985 | 8,509 (0%) | 0% | 80 | 318,800 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 75.57 per share. | 09 Jul 2025 | 3,984 | 12,494 (0%) | 0% | 75.6 | 301,051 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 37,500 | 37,500 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 25,000 | 25,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,125 | 12,375 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 4,125 | 9,737 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 1,228 | 8,509 (0%) | 0% | 57.2 | 70,266 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 56.39 per share. | 12 Feb 2025 | 462 | 5,619 (0%) | 0% | 56.4 | 26,052 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.14 per share. | 12 Feb 2025 | 7 | 5,612 (0%) | 0% | 57.1 | 400 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,656 | 5,313 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,656 | 2,656 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,562 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 1,562 | 6,875 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.51 per share. | 09 Feb 2025 | 791 | 6,084 (0%) | 0% | 57.5 | 45,490 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 57.67 per share. | 09 Feb 2025 | 3 | 6 (0%) | 0% | 57.7 | 173 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,938 | 7,874 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,938 | 3,938 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 59.43 per share. | 01 Feb 2025 | 1,281 | 2,657 (0%) | 0% | 59.4 | 76,130 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 7,969 | 19,922 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 11 Nov 2024 | 7,969 | 7,969 (0%) | 0% | 6.8 | 54,189 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 65.73 per share. | 11 Nov 2024 | 6,604 | 6,677 (0%) | 0% | 65.7 | 434,075 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 67.05 per share. | 11 Nov 2024 | 5,977 | 700 (0%) | 0% | 67.1 | 400,782 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 11 Nov 2024 | 5,312 | 13,281 (0%) | 0% | 21.4 | 113,571 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 5,312 | 0 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 67.83 per share. | 11 Nov 2024 | 700 | 0 (0%) | 0% | 67.8 | 47,484 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 16 Jul 2024 | 10,468 | 10,498 (0%) | 0% | 27.4 | 286,300 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 10,468 | 23,032 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 53.00 per share. | 16 Jul 2024 | 10,468 | 30 (0%) | 0% | 53.0 | 554,817 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 12 Jul 2024 | 5,313 | 5,343 (0%) | 0% | 21.4 | 113,592 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 12 Jul 2024 | 5,313 | 30 (0%) | 0% | 50.0 | 265,725 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jul 2024 | 5,313 | 1,297 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 May 2024 | 3,984 | 4,014 (0%) | 0% | 6.8 | 27,091 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 3,984 | 31,875 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 38.38 per share. | 09 May 2024 | 3,484 | 530 (0%) | 0% | 38.4 | 133,708 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 39.10 per share. | 09 May 2024 | 500 | 30 (0%) | 0% | 39.1 | 19,551 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 40.34 per share. | 21 Mar 2024 | 18,235 | 30 (0%) | 0% | 40.3 | 735,600 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 15,515 | 18,265 (0%) | 0% | 39.2 | 608,498 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 50,250 | 50,250 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 33,750 | 33,780 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 16,500 | 16,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 13 Feb 2024 | 1,865 | 1,119 (0%) | 0% | 50 | 93,250 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 13 Feb 2024 | 1,089 | 30 (0%) | 0% | 50.0 | 54,461 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 69,190 | 6,610 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 69,190 | 74,460 (0%) | 0% | 21.4 | 1,479,282 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 65,175 | 70,415 (0%) | 0% | 21.4 | 1,393,442 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 65,175 | 10,625 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.14 per share. | 09 Feb 2024 | 48,177 | 26,183 (0%) | 0% | 50.1 | 2,415,503 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.88 per share. | 09 Feb 2024 | 23,397 | 2,786 (0%) | 0% | 50.9 | 1,190,503 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,985 | 31,875 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Feb 2024 | 3,985 | 74,430 (0%) | 0% | 6.8 | 27,098 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,656 | 5,312 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,656 | 5,270 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,562 | 4,248 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 1,562 | 1,562 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 09 Feb 2024 | 791 | 3,457 (0%) | 0% | 51.4 | 40,642 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 49.84 per share. | 09 Feb 2024 | 473 | 2,984 (0%) | 0% | 49.8 | 23,574 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 48.24 per share. | 09 Feb 2024 | 100 | 74,360 (0%) | 0% | 48.2 | 4,824 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 51.52 per share. | 09 Feb 2024 | 100 | 2,686 (0%) | 0% | 51.5 | 5,152 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,938 | 3,938 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,938 | 11,812 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Feb 2024 | 1,324 | 2,614 (0%) | 0% | 45.1 | 59,659 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 27 Dec 2023 | 7,926 | 0 (0%) | 0% | 50.0 | 396,318 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 6,800 | 75,800 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 27 Dec 2023 | 6,800 | 7,926 (0%) | 0% | 21.4 | 145,384 | Common Stock |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 27 Dec 2023 | 5,015 | 1,126 (0%) | 0% | 50.0 | 250,796 | Common Stock |